Alto Neuroscience (ANRO) Profit After Tax (2023 - 2026)
Alto Neuroscience (ANRO) reported Profit After Tax of -$26.2 million for Q1 2026, down 22914.78% on a YoY basis from N/an in Q1 2025, and down 328062.5% sequentially from $8000.0 in Q4 2025.
Alto Neuroscience (ANRO) Profit After Tax (2023 - 2026) Analysis & Trends
Alto Neuroscience (ANRO) has 4 years of Profit After Tax data on file, last reported at -$26.2 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax fell 22914.78% year-over-year to -$26.2 million; the trailing twelve-month figure through Mar 2026 stood at -$58.1 million (down 530.17% YoY), and the FY2025 full-year result was $123000.0, up 659.09% from the prior year.
- Profit After Tax fell to -$26.2 million in Q1 2026, from $8000.0 in the prior quarter.
- In the past five years, Profit After Tax ranged from a high of $46.2 million in Q4 2024 to a low of -$26.2 million in Q1 2026.
- A 4-year average of -$5.7 million and a median of -$8.7 million in 2023 frame the typical range for Profit After Tax.
- Peak annual rise in Profit After Tax reached 660014.29% in 2024, while the deepest fall reached 167730.0% in 2024.
- Tracing ANRO's Profit After Tax over 4 years: stood at $7000.0 in 2023, then jumped by 660014.29% to $46.2 million in 2024, then plunged by 99.98% to $8000.0 in 2025, then plunged by 328062.5% to -$26.2 million in 2026.
- Business Quant data shows ANRO's Profit After Tax at -$26.2 million in Q1 2026, $8000.0 in Q4 2025, and -$14.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.84 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -14.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 227.36 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.60 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 498.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Alto Neuroscience | 869.36 Mn | 869.36 Mn | - | -26.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -26.24 Mn |
| Dec 31, 2025 | 8,000.00 |
| Sep 30, 2025 | -14.18 Mn |
| Jun 30, 2025 | -17.71 Mn |
| Mar 31, 2025 | 115,000.00 |
| Dec 31, 2024 | 46.21 Mn |
| Sep 30, 2024 | -16.78 Mn |
| Jun 30, 2024 | -16.03 Mn |
| Mar 31, 2024 | -13.42 Mn |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | -10,000.00 |
| Jun 30, 2023 | -8.66 Mn |
| Mar 31, 2023 | -7.28 Mn |